Mycobacterium tuberculosis-specific recombinant proteins CFP10-ESAT6, for skin testing (0.2 µg/0.1 ml).
Introduction
The diagnosis and treatment of latent tuberculosis infection (LTBI) is one of the strategies recommended by the World Health Organization (WHO) to combat tuberculosis (TB) worldwide and is part of the WHO strategy for tuberculosis control [1] . With regard to acceptable methods for diagnosing LTBI, WHO documents recommend that either a tuberculin test (TST) or an IGRA test be used to detect LTBI in high-income and middle-income countries and a TB incidence of <100 per 100,000 population. TST is preferred in low-and middle-income countries with an incidence of 4 induration of ≥ 5mm, ≥ 10mm or ≥ 15mm) depends on an individual's risk factor profile for TB.
Usually, a lower cut-off value of ≥ 5mm is used for individuals at higher risk of TB and a higher cut-off value of ≥ 10mm is applied for individuals at lower risk of TB [21, 22, 23] .
The above-mentioned limitations are compounded by issues related to the interpretation of test results, which may independently influence false-positive and false-negative rates of the TST (e.g. different cut-off values, PPD dose) [20, 21, 24] .
In general, both pooled sensitivity and specificity values of the IGRAs and the TST were similarly high in people who were not vaccinated with BCG (> 90%); however, the pooled specificity of the TST in BCG-vaccinated populations was much lower than that of IGRAs (about 56% vs. 96%) [25, 26, 27] .
In contrast, prospective longitudinal studies showed that neither the IGRAs nor the TST had a high prognostic value in predicting the risk of progression to active TB [27, 28] . Sollai S. et al., [29] in their meta-analysis conducted a comparative analysis of the sensitivity of IGRA tests and Mantoux skin test in high and low income countries for the first time. In high-income countries, the QFT-G-IT sensitivity was 0.79 (95 % CI 0.75-0.82). In lowincome countries, the sensitivity of QFT-G-IT was significantly lower: 0.57 (95 % CI 0.52-0.61.
The higher specificity of IGRA versus TST was observed in high-income countries (97-98 % vs. 92 %), but not in low-income countries (85-93 % vs. 90 %).
Five meta-analyzes published earlier evaluated the sensitivity and specificity of IGRA in children, but the data on the overall assessment vary considerably. In them, similarly to the data presented in adults, IGRA was reported to be more specific in comparison with TST. However, the IGRA sensitivity was 62 % to 89 % for T-SPOT.TB and 66 % to 83 % for QFT-G-IT [26, [30] [31] [32] [33] .
Thus, the currently available information is insufficient to assess the sensitivity, specificity and reproducibility of IGRA tests in children.
IGRA tests, having high specificity, still have a number of serious disadvantages: high material costs, the need for an equipped laboratory, intravenous manipulation and the precautionary requirements for maintaining the viability of lymphocytes producing INF-γ, which does not allow this method to be used for mass diagnostics.
The solution of the problem for Russia was the introduction of a skin test with CFP10 and ESAT6 proteins. In Russia, the medicinal product Diaskintest ® (manufactured by Generium according to the GMP standard) was developed, which is a complex of CFP10/ESAT6 recombinant proteins, produced by Escherichia coli, BL21 (DE3) / pCFP-ESAT, intended for setting an intradermal test in a dose of 0.1 μ g/0.1 ml according to the Mantoux test technique [34] . The test has been widely used in Russia since 2009 according to the order of the Ministry of Health of Russia.
Similar to the Russian test, the Danish skin test with C-Tb was developed, which is produced by Statens Serum Institut in accordance with the GMP standard (Copenhagen, Denmark) -the difference is that it is a mixture of two recombinant proteins ESAT-6 and CFP-10 in the ratio of 1:1. Both proteins are produced by Lactococcus lactis, the dose of the drug for intradermal application is 0.1 μ g/0.1 ml. The test underwent 3 phases of clinical trials [35] [36] [37] [38] .
In general, compared to TST based on PPD, IGRA tests and new skin tests Russian Diaskintest and Danish C-tb test may offer additional benefits, especially improved specificity [39] . Of course, the availability of new tools is a critical factor for expanding their application, these are cost-effectiveness and feasibility in conditions of a lack of resources [40].
Recent international reviews of WHO strategy END TB specify the priority tasks: development of biomarkers for the detection and diagnosis of tuberculosis in children and people from high-risk groups, including systematic screening (active search for TB cases); detection of latent tuberculosis infection -to reduce the pool of individuals with LTBI; evaluation of treatment effectiveness. A biomarker shall have low cost -for TB diagnostics at the primary 6 healthcare level [18] . Since there is no diagnostic standard for LTBI, active tuberculosis is used as a comparable substitute, although tuberculosis is known to be immunosuppressive.
Study purpose: study of the comparative sensitivity of Mantoux test with 2 TU PPD-L and a skin test with tuberculous recombinant allergen (Diaskintest) containing the ESAT6-CFP10 protein in newly diagnosed tuberculosis in children and adolescents registered in 2013-2016 in Moscow in a mass application of tests in the primary medical service.
Materials and methods

Study designs
The design of the study -a full-design retrospective group study of children and adolescents diagnosed in Moscow with respiratory tuberculosis in 2013-2016.
In Russia, all children are to be vaccinated with BCG after birth and revaccinated at the age of 7 provided that they have a negative Mantoux test with 2 TU PPD-L. Every year in Moscow all children and adolescents are screened with the Mantoux test with 2TU PPD-L (Saint Petersburg RDE of Vaccines and Serums FMBA of Russia) in order to assess the presence of post-vaccination allergy and identify a changed sensitivity to tuberculin (a positive reaction after complete test extinction, an increase in the positive reaction of 6 mm or more). Every year in Moscow, all children and adolescents are subject to a scheduled Mantoux test with 2 TU PPD-L (TST) to detect a change in response to a tuberculin test (the appearance of a positive reaction, an increase in the positive response by 6 mm or more). A cut-off Sometimes, at the request of parents, children are given two tests simultaneously on different hands.
Persons with a positive reaction to Diaskintest are subject to a thorough examination to identify local forms of tuberculosis (pulmonary and extrapulmonary). This is a computed tomography of chest organs, ultrasound of other organs, and in the presence of changes in the lungs -a sputum examination on MBT culture and molecular genetic methods. In the presence of local changes in the chest, including the intrathoracic lymph nodes and the pleura, children are subject to a commission assessment of changes in order to establish a diagnosis of tuberculosis or the presence of post-tuberculosis changes. The commission consists of the most qualified phthisiatricians and radiologists. If a diagnosis of tuberculosis is established, the children are hospitalized in a 24-hour in-patient facility and given anti-tuberculosis therapy, depending on the severity of the process, the availability of drug resistance, but at least 6 months. All antituberculosis activities are free, regardless of whether they are permanent Moscow residents or migrants. Children with positive reactions without local changes are subject to preventive therapy for at least 3 months on an outpatient basis or in a sanatorium and are observed during the year.
There was no formal sample size. The study was conducted as a full-design study.
Main approaches to the statistical analyses
Descriptive statistics
The results contains the descriptive statistics of the subjects included to this study. For quantitative variables (age, the numeric results of the diagnostic tests, etc.) the following statistics presented: number of valid values (N); minimum (Min); maximum (Max); arithmetic mean (M); standard deviation (SD); 95% confidence interval (CI) for the mean; median (Me); 8 interquartile range (IQR). Categorical data (such as gender, a group of the subject, etc.) presented with frequency in a format n/N and percentage (%).
Analyses of the test results
Data on sensitivity of the immunological tests presented as frequencies in a format n/N, where n is the number of subjects with true positive test results and N is number of subjects included to the analysis, as well as respective percentage (%).
McNemar test was applied to compare the results on sensitivity and concordance/disconcordance of the two tests and to estimate the odds ratios (OR) for a true positive result under different cut-off levels applied. To reveal chance-corrected agreement between the two tests, the kappa coefficients were calculated. The data presented with all the count a-b-c-d for two-by-two tables under different combinations of the test results.
Quantitative results of the two tests (size of indurations in mm) were analyzed with Pearson correlation and paired t-test. The point estimate for the mean differences in induration sizes along with 95% CI are shown. All parents give written informed consent for carrying out skin tests and any manner of examination and treatment. The patients' parents gave their consent to the processing of the study data provided that no personal information is published. Access to medical documents for the conduct of this study was granted on November 17, 2016.
Ethical approvals
Software
All the statistical analyses were performed using Stata ver. 14 (StataCorp LP, www.stata.com. Stata Statistical Software: Release 14. College Station T:SL, 2).
Results and discussion
Results
Analyses of baseline characteristics of the subjects
The following age category of subjects was included in the study: children and adolescents aged 0 to 17 years inclusive -total 441. Out of 441 patients, the results of the Diaskintest are known in 421 people, TST-in 414 people (the reasons of no TST results were: parents refusal to perform TST having only Diaskintest done; no data for patients who are not residents, although they were in the territory of Moscow, entered the official statistics of morbidity, received treatment in federal healthcare institutions and left for home, without submitting documents to the Moscow TB Service). The mean age of the patients is 8.8 ± 5.8 years. Data on the average age of subjects in each of these subgroups are summarized below (Table 1) . 234 patients (55.6 %) were female and 187 (44.4 %) were male (S1 Table) .
Out of 421 patients, 408 patients had the results of both tests, 193 patients were simultaneously given 2 tests: TST with 2 TU PPD-L and Diaskintest, 162 of whom were BCGvaccinated, 10 were not vaccinated, no data were reported for 21, due they were migrants. The diagnosis of tuberculosis is confirmed by the discovery of the pathogen in a small number of cases (13/421 -3.1 %). The main diagnosis is based on a combination of clinical and radiological data.
In the overwhelming majority of cases, tuberculosis of the intrathoracic lymph nodes (about 50 %, Table 2 ) was noted among children and adolescents under 17 years
with a confirmed diagnosis of tuberculosis. The simultaneous diagnostics with both the tests was performed for 193 subjects (Table   5 . Fig 1) . The results for those patients were very close to the results for the above-mentioned 408 subjects. show a true positive result (OR = 0.37 with 95% CI 0.25-0.55). The results obtained for the BCG vaccinated patients with simultaneous diagnostics performed ( The results for non-vaccinated patients with simultaneous tests were not statistically significant due to a small sample size (n = 10) (S2 Table) . Generally, the patients in all the samples have shown a higher induration size for Diaskintest compared with TST. The analysis performed with a paired t-test has shown statistically significant differences (p < 0.001) except for the non-vaccinated patients with simultaneous diagnostics performed, where only a small sample size was available (Fig 3, S1 Fig 3) . The difference was on average 1.9 mm (with 95% CI 1.4-2.4 mm) for all the patients with both the test results present. Similar effect size was found for the patients with simultaneous diagnostics The high sensitivity of Diaskintest in children can be explained by the optimal diagnosis of the disease, which is facilitated by the fact that children from 1 year of age are subject to 2 0 annual tuberculin diagnostics, the moment of primary infection is fixed and they are subject to examination at the phthisiatrician. Our comparative studies of the sensitivity of Diaskintest and QuantiFERON-TB Gold In-Tube ® tests showed high sensitivity of not only Diaskintest, but also QuantiFERON-TB Gold In-Tube ® (more than 90 %) [45] , which can be explained by the adequate diagnosis of tuberculosis in children, which is a difficult task in the absence of clinical manifestations and bacterial excretion. After the introduction of Diaskintest to wide practice in 2010 and the prescription of preventive therapy to children with a positive reaction, the incidence of tuberculosis in Moscow in 2016 decreased from 10.6 to 5.5. The incidence in adolescents showed a decrease from 28.7 to 11.6, with the incidence of the resident population almost 2 times lower in both children and adolescents [46] . An important role is played by the fact that the Diaskintest test is simple to perform, it is currently used in primary health care, it is cheap (the cost is similar to the Mantoux test) and is now implemented by the order of the Ministry of Health into the practice of Russia as a screening method instead of Mantoux test in children over 7 years old. 2 1 In children and adolescents with tuberculosis, Diaskintest at a dose of 0. Supporting information S1 Table. Gender distribution of the patients, n= 421.
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S2 Table. Comparison of the results between TST and Diaskintest at different cut-off levels
on the sample of non-vaccinated patients with simultaneous diagnostics performed (n = 10).
S1 Fig 3. Descriptive statistics of the induration size (mm) of the Diaskintest (n=421) and
TST, n=414.
